THE EFFECT OF TREATMENT WITH CONJUGATED EQUINE ESTROGEN PREPARATIONS ON 17-KETOSTEROID AND PREGNANEDIOL EXCRETION IN MALE SUBJECTS WITH MYOCARDIAL INFARCTION.
D015068:17-Ketosteroids; D000738:Androsterone; D004966:Estrogens, Conjugated (USP); D005043:Etiocholanolone; D009203:Myocardial Infarction; D010600:Pharmacology; D011276:Pregnanediol; D014556:Urine
D015068:17-Ketosteroids; D004966:Estrogens, Conjugated (USP); D005043:Etiocholanolone; D000738:Androsterone; D011276:Pregnanediol
17-KETOSTEROIDS; ANDROSTERONE; ESTROGENIC SUBSTANCES, CONJUGATED; ETIOCHOLANOLONE; MYOCARDIAL INFARCT; PHARMACOLOGY; PREGNANEDIOL; URINE